Fig. 1 · Structure

Documents & Downloads

Isochlorogenic acid A

Cat. No. A12072 CAS 2450-53-5
Botanical Source: globe artichoke (Cynara scolymus), quince fruit (Cydonia oblonga), Caucasian whortleberry (Vaccinium arctostaphylos), Aster scaber and Ipomoea batatas (sweet potato) tubers

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Isochlorogenic acid A Research Summary

This section summarizes 2 in vitro studies and 1 in vivo study of Isochlorogenic acid A from 2 published references. In vitro models include porcine pancreatic lipase (type II); HNE.

Isochlorogenic acid A In Vitro Studies

Isochlorogenic acid A showed dose-dependent inhibitory activity in a porcine pancreatic lipase assay using buffer solution as the control. In an HNE assay with Elaspol as the control, Isochlorogenic acid A inhibited HNE activity. [1,2]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Isochlorogenic acid A inhibits porcine pancreatic lipase

Cell-based study · Porcine pancreatic lipase (type II) [1]

In a porcine pancreatic lipase assay, Isochlorogenic acid A showed dose-dependent pancreatic lipase inhibitory activity, with buffer solution used instead of the tested sample as the control.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
pancreatic lipase inhibitory activitiesIC50 0.081 ± 0.012 mg/ml[1]

Literature-Reported Treatment Conditions

Treatment concentration
0.039, 0.078, 0.156., 0.312, and 0.625 mg/ml
Exposure duration
pre-incubation at 37°C for 10 min; incubation at 37°C for 20 min
Method
added into a black bottom 96-well plate
Vehicle
Tris-HCl buffer solution (13 mM Tris-HCl, 150 mM NaCl, 1.3 mM CaCl2, pH 8.0)
Methods and source locations

Compound reported in the paper: Isochlorogenic acid A

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Materials and Methods > Materials and Reagents (S6); Materials and Methods > Pancreatic Lipase Inhibition Assay (S32, S33, S34, S35, S36, S38, S43); Results > Verification of Pancreatic Lipase Inhibitory Activity (S117, S119, S120)

pancreatic lipase inhibitory activities: pancreatic lipase inhibitory activities; comparator: buffer solution instead of tested sample — Materials and Methods > Pancreatic Lipase Inhibition Assay (S43); Results > Verification of Pancreatic Lipase Inhibitory Activity (S120)

Isochlorogenic acid A inhibits HNE activity

Cell-based study · HNE [2]

In an HNE assay with Elaspol as the control, Isochlorogenic acid A inhibited HNE activity with an IC50 value of 1.86 ± 0.06 μM.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
HNE activityIC50 1.86 ± 0.06 μM[2]

Literature-Reported Treatment Conditions

Reported limits
Not stated in the sentences used: dose, route, schedule, vehicle.
Methods and source locations

Compound reported in the paper: Isochlorogenic acid A; Compound label in the paper: 3 5-DCQA

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > 3,5-DCQA (compound 6) showed potent and selective inhibition of HNE activity (S16); Table 1 legend (S147)

HNE activity: HNE activity; comparator: Elaspol — Results > 3,5-DCQA (compound 6) showed potent and selective inhibition of HNE activity (S16)

Isochlorogenic acid A In Vivo Studies

Male ICR mice with LPS-induced ALI received Isochlorogenic acid A at 50 mg/kg intraperitoneally before LPS exposure. Pretreatment significantly improved pathological features compared with the LPS group. [2]

Isochlorogenic Acid A in LPS-Induced ALI

Animal study · Male ICR mice; LPS-induced ALI; n = 6 per group [2]

These pathological features were significantly improved following pretreatment with 3,5-DCQA (50 mg/kg).

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Wet/dry (W/D) weight ratioReported result These pathological features were significantly improved following pretreatment with 3,5-DCQA (50 mg/kg).[2]

Conditions shared by the study groups

Route
intraperitoneally
Treatment course
1 h before PBS or LPS; sacrificed at 6 h post-dosage
Vehicle
PBS containing 10% Tween-80
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Isochlorogenic acid A 50 mg/kgLPSThese pathological features were significantly improved following pretreatment with 3,5-DCQA (50 mg/kg).[2]
Isochlorogenic acid A 50 mg/kg
Model: Male ICR mice; LPS-induced ALI; n = 6 per group
Methods and source locations

Compound reported in the paper: Isochlorogenic acid A; Compound label in the paper: 3 5-DCQA

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > IKWE and 3,5-DCQA protected against LPS-induced ALI in mice (S39, S40, S43, S44); Methods > Animals (S83); Methods > LPS-induced ALI in mice (S93, S94, S95, S96, S97, S102); Figure 5 legend (S129, S138)

Wet/dry (W/D) weight ratio: Wet/dry (W/D) weight ratio; comparator: LPS — Results > IKWE and 3,5-DCQA protected against LPS-induced ALI in mice (S40, S43, S44)

Isochlorogenic acid A 50 mg/kg · Results > IKWE and 3,5-DCQA protected against LPS-induced ALI in mice (S40, S43); Methods > LPS-induced ALI in mice (S93, S95, S97)

Specifications

Manufacturer Adooq Bioscience
CAS Number 2450-53-5
Formula C25H24O12
Molecular Weight 516.45
SMILES
C1C(C[C@H](C([C@@H]1OC(=O)/C=C/C2=CC(=C(C=C2)O)O)O)OC(=O)/C=C/C3=CC(=C(C=C3)O)O)(O)C(=O)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 96 mg/mL (185.88 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Isochlorogenic acid A Research References

  1. [1] Chang Y, Zhang D, Yang G, et al. Screening of Anti-Lipase Components of Artemisia argyi Leaves Based on Spectrum-Effect Relationships and HPLC-MS/MS. Front Pharmacol (2021). PMID: 34025435 DOI: 10.3389/fphar.2021.675396 Source material
  2. [2] Chen YL, Hwang TL, Yu HP, et al. Ilex kaushue and Its Bioactive Component 3,5-Dicaffeoylquinic Acid Protected Mice from Lipopolysaccharide-Induced Acute Lung Injury. Sci Rep (2016). PMID: 27681838 DOI: 10.1038/srep34243 Source material

Added to your cart

View Cart Checkout
Loading...